PLATELET FUNCTION ANALYZER: Anysis System

PLATELET FUNCTION TESTS in LESS THAN 5 MINUTES

Anti-platelet Therapy Response Assessment

The Anysis system test provides assessment for inherited, acquired, or drug-induced platelet dysfunction.

Through in-vivo vascular mimicking microfluidics, the system measures a realistic primary hemostasis associated with platelet function.

🔎 Key Features of Anysis

✔​ Whole blood hemostasis assay

✔​​ Similar to in vivo vascular environment

​✔ Test time: ~ 4min/test

​✔ Sample volume: 200uL

✔ Result: ​Measurement of how far the blood has migrated is the index for assessing the platelet function. The longer the distance migrated, the stronger the dysfunction of the platelets.

🩸 4 Types of Test Kits

Collagen/ADP test

Collagen/EPI (Epinephrine) test

Aspirin test

P2Y12 test

#Thrombosis

#ADP #Epinephrine #Aspirin #P2Y12

#rheomeditech #PFA #ANYSIS #plateletfunctiontest

RheoScan Series IFU

D-TEST Cartridges

① RSD-K01 Critical Shear Stress (Aggregation-1)

② RSD-K02 Deformability (consists of K01 + pvp sol.) IMPORTANT* PVP Solution must be stored in 2-8ºC.** Expiration date: 5-6 months after manufactured Best to use within 3 months. ​ (You may separately buy PVP solutions in bulk.)

A-TEST Cartridges

③ RSA-C01 (Aggregation-2)

IFU RheoScan (ENG).pdf

Download PDF • 604KB

If you have any questions, please feel free to contact us.

info@any-sis.com Customer service.

What is RBC deformability and why is it important?

Red blood cells (RBCs) have ability to undergo large deformations when subjected to stresses, which allows the RBCs to pass through capillaries narrower than resting RBC diameter.

A slight decrease in red cell deformability may cause important disturbances in the blood circulation of micro-vessels, but also in blood vessels whose lumen is diminished markedly by atherosclerosis or thrombosis.

Recent clinical observations have reported that reduced RBC deformability is a common risk factor for circulation diseases including diabetes, sepsis, malaria, hypertension, sickle cell anemia, myocardial ischaemia, stroke and other circulation disorders. A growing body of scientific evidences indicates that cell deformability can be used to identify patients at risk for cardiovascular diseases at earlier stage.

Cell deformability test - one that is performed at the patient point of care and that delivers results in just a minute - would give healthcare providers a valuable tool for diagnosing and preventing circulation disorders.